Boston Scientific | BSX - Current Assets

Stock Price
62.07
Daily Change
-3.62 -5.51%
Monthly
-11.05%
Yearly
-39.09%
Q2 Forecast
62.82

Boston Scientific reported $8.79B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
CONMED USD 672.86M 10.7M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Danaher USD 13.94B 1.18B Mar/2026
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.74B 380M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025